Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.

about

Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.

Item

http://www.wikidata.org/entity/Q53828437

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Anti-fibrotic effects of pirfe ...... man alveolar epithelial cells.

@en

Anti-fibrotic effects of pirfe ...... man alveolar epithelial cells.

@nl

type

Item

label

Anti-fibrotic effects of pirfe ...... man alveolar epithelial cells.

@en

Anti-fibrotic effects of pirfe ...... man alveolar epithelial cells.

@nl

prefLabel

Anti-fibrotic effects of pirfe ...... man alveolar epithelial cells.

@en

Anti-fibrotic effects of pirfe ...... man alveolar epithelial cells.

@nl

P1476

Anti-fibrotic effects of pirfe ...... man alveolar epithelial cells.

@en

P2093

A Montes-Worboys

http://www.w3.org/2001/XMLSchema#string

I Escobar

http://www.w3.org/2001/XMLSchema#string

M Molina-Molina

http://www.w3.org/2001/XMLSchema#string

P Luburich-Hernaiz

http://www.w3.org/2001/XMLSchema#string

R Llatjós

http://www.w3.org/2001/XMLSchema#string

V Vicens-Zygmunt

http://www.w3.org/2001/XMLSchema#string

P2860

TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices.

Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.

In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion.

Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.

Clinical significance of mTOR, ZEB1, ROCK1 expression in lung tissues of pulmonary fibrosis patients

P2888

s12890-018-0626-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12890-018-0626-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jordi Dorca

Ernest Sala-Llinas

Carlos Machahua

P577

2018-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103669475

http://www.w3.org/2001/XMLSchema#string

P698

29703175

http://www.w3.org/2001/XMLSchema#string

P932

5922028

http://www.w3.org/2001/XMLSchema#string